therefore depend on the completeness of your responses in this revised version.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://emboj.embopress.org/about#Transparent_Process
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
REFEREE REPORTS Referee #1:
This paper by Jones & Ferré-D'Amaré describes the 3.2 A resolution structure of the yadO aptamer together with its ligand, c-di-AMP. C-di-AMP is a recently discovered second messenger in bacteria whose physiological functions have begun to be investigated in several organisms. As does its close cousin, c-di-GMP, c-di-AMP is primarily sensed by cellular proteins but can also be recognized by RNA molecules such as the ydaO riboswitch studied here.
In their paper, the authors discuss the obtained structural details of their co-crystal (with protein U1A upon engineering a binding site in the RNA) and perform perturbation experiment, synthesizing mutated RNA variants and using ITC to address which structural elements are required for c-di-AMP binding and discrimination against similar ligands. They also reveal that one aptamer binds two c-di-AMP molecules and propose a model whereby the binding of two ligands induce a global structural rearrangement that underlies regulation in vivo.
Specific comments:
1. This paper will be interesting, in principle, for many researchers studying the sensing of nucleotides by RNA molecules as well as those interested in c-di-AMP. That said, it remains a purely structural paper with no attempt to validate the importance of any of the proposed key nucleotides in the ydaO aptamer in vivo. Whether or not EMBO J will publish a relatively short structural paper without any functional validation of the results in a more physiological setting will have to be an editorial decision.
2. The two previous papers on the ydaO RNA have produced conflicting results with respect to the ligand. Watson & Fedor 2012 reported that this aptamer-in Bacillus subtilis-is an ATP-sensing riboswitch whereas the Breaker lab (Nelson et al. 2013) reported it as a c-di-AMP riboswitch. However, this is never explicitly discussed in the paper; by contrast, the authors seem to shy away from even mentioning the conflicting previous results (see paragraph on page 5). The authors having crystalized the Bacillus ydaO aptamer should be more explicit as to whether its primary ligand is cdi-AMP or ATP.
3. The authors propose that two c-di-AMP molecules are required to bring about an overall structural change that leads to regulation of gene expression by the riboswitch. This model should be strengthened by analysis of mutant RNAs that can bind only one c-di-AMP molecule.
Referee #2:
This short paper reports on the structure of the cyclic adenosine monophosphate responsive riboswitch. Several structures of riboswitches are known but they all display surprising structural diversities and binding mechanisms. This structure is no exception. Two three-way junctions associate pseudo-symmetrically with each one binding a c-di-AMP. The paper is well written and structurally very rich with comparisons to other second messenger cyclic-dinucleotides binding to RNAs or proteins. I have just a couple of points. First, a standard 2D diagrams would be welcome, if only to stress the unexpected quasi-symmetry (can be in supplementary material). Secondly, the discussion on the three-way junctions is very interesting. It could be worth remarking that in the purine riboswitches, the purines bind also to a three-way junction that encapsulates the purine moiety while maintaining sugar-edge contacts to one of the three helices (for a discussion and refs, see Chem. & Biol. 12, 10 (2005) ). Here, the two junctions are not exactly those described by Geary et al (and previously in RNA 12, 83 (2006) ). In type C junctions, the A-minor contacts between P3 (parallel to P1) are to helix P2 (stacked with P1). In the present and interesting situation, the GNRAlike motifs do not appear to bind to the minor groove of a stacked helix; but one A from each of the c-di-AMP does, pushing up helices P1 and P4, respectively. In the absence of c-di-AMP, the GNRA like motifs might be binding to helices P3 and P6.
Referee #3:
Cyclic dinucleotides are emerging regulators of both bacterial and eukaryotic signaling, and molecular understanding of the machinery responsible for synthesis and recognition of cyclic dinucleotides is of broad general interest. Jones and Ferré-D'Amaré extend upon the recent discovery of a conserved family of c-di-AMP riboswitches in bacteria (B. subtilis ydaO for example), and present an x-ray crystal structure of ydaO bound to c-di-AMP. Their structure reveals an unexpected pseudo-symmetrical binding cleft formed by two RNA halves coordinating a pair of c-di-AMP molecules, and explains previous biochemical observations regarding ydaO cyclic dinucleotide discrimination. In addition, Jones and Ferré-D'Amaré perform SAXS to characterize bound and unbound states, and ITC binding experiments to support critical interactions observed in their co-crystal structure.
Overall the work of this paper is excellent, and should be of general interest to the readership of EMBO J.
Specific Comments 1) Currently the authors have no discussion about how c-di-AMP binding and riboswitch activation leads to gene expression changes. The authors should comment on how their bound structure could lead to the transcriptional arrest phenotype previously characterized, i.e. is it the specific structure that leads to transcription termination or something about the stability of the c-di-AMP interaction? Some speculation or data relevant to this point is warranted given that this is the biological role of the state crystallized in this work.
2) The authors should comment on their ability to accurately determine the exact orientation of c-di-AMP in the structure given their resolution. Are alternative positions possible given the data?
3) The authors insert the U1A binding site in many locations throughout the mutagenesis and RNA preparation sections. It would be helpful to the reader if in each case (text, tables and figures) it were clearer which construct was the actual crystallized variant.
Minor Comments 1) Page 15, paragraph 1 and paragraph 2 seem to begin and end with the same sentence. Consider merging the two thoughts for clarity?
2) Page 15, the authors should consider referencing other groups as well for the first STING c-di-GMP structures, as several groups reported similar findings at the same time. We agree with the reviewer that this is primarily a structural paper, and the revised version does not attempt any in vivo characterization of the RNA. However, we have endeavored to flesh out more functional implications of the structure by performing additional biochemical characterization of site-directed riboswitch mutants. These include mutations at nucleotides contacting the bound c-di-AMP molecules, as well as nucleotides stabilizing the conformation of those "first-tier" nucleotides. The results of mutagenesis all strongly support our interpretation of the crystal structure. Table 2 , and discussed in the text as well (lines 235-236 and 312-314).
Moreover, we have extended our biophysical analysis of ligand recognition to a homologous ribozyme from a different bacterium (Thermoanaerobacter tengcongensis). This new information is shown in

The two previous papers on the ydaO RNA have produced conflicting results with respect to the ligand. Watson & Fedor 2012 reported that this aptamer-in Bacillus subtilis-is an ATP-2 sensing riboswitch whereas the Breaker lab (Nelson et al. 2013) reported it as a c-di-AMP riboswitch. However, this is never explicitly discussed in the paper; by contrast, the authors seem to shy away from even mentioning the conflicting previous results (see paragraph on page 5). The authors having crystalized the Bacillus ydaO aptamer should be more explicit as to whether its primary ligand is c-di-AMP or ATP.
Previously, we had not included a thorough discussion of this topic, because we felt that it had been sufficiently addressed in work originally identifying c-di-AMP to be the ydaO riboswitch ligand (Nelson et al, 2013), referenced throughout. However, following the suggestion of this referee, we have now included the following on lines 186-88: "Moreover, the majority of these hydrogen bonds would be absent for ATP, which was previously proposed to be the cognate ligand (Watson & Fedor, 2012) but binds the riboswitch with at least 10^6-fold weaker affinity than c-di-AMP (Nelson et al, 2013) ."
The authors propose that two c-di-AMP molecules are required to bring about an overall structural change that leads to regulation of gene expression by the riboswitch. This model should be strengthened by analysis of mutant RNAs that can bind only one c-di-AMP molecule.
In our newly included biochemical analyses of structure-guide site-directed mutant riboswitches, we have mutated each of the two binding sites and and find that, in general, both are required for high affinity binding. This strongly supports our contention that two c-di-AMP molecules are needed to bring about the genetic decision. These data are summarized in Table 2 and discussed on lines 301-319: "As expected, mutation of residues in contact with cdi-AMP generally results in a loss of binding. Despite observing 1:1 binding in all B. subtilisderived RNAs except for A9U, the two binding sites appear to be linked as mutation to either site in most cases eliminates binding under our conditions. This may be partly explained by the extensive stacking interactions and domain-domain interactions connecting the two binding sites …" & Biol. 12, 10, 2005) . Here, the two junctions are not exactly those described by Geary et al (and previously in RNA 12, 83 (2006) 2) The authors should comment on their ability to accurately determine the exact orientation of c-di-
